Live Breaking News & Updates on Gabriel Castano

Stay updated with breaking news from Gabriel castano. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ENDO 2024 Roundup: Teen GLP-1 Coverage; Novel CAH Drug; Hot Flash Risks

More research from the Endocrine Society's annual meeting ....

New York , United States , Eleni Armeni , Gabriel Castano , Umasuthan Srirangalingam , University College London Hospitals , Texas Children Hospital Baylor College Of Medicine , Aretaieio Hospital National , Kapodistrian University Of Athens , Crinetics Pharmaceuticals , Endocrine Society , Texas Children , Hospital Baylor College , Kapodistrian University , New York City ,

GLP-1 Coverage Often Denied for Teens With Obesity

Half of adolescents who did fill prescriptions never reached their treatment dose, according to a single-center retrospective study. ....

United States , Eric Bomberg , Gabriel Castano , University Of Minnesota Medical School In Minneapolis , Drug Administration , Endocrine Society , Division Of Pediatric Endocrinology , Texas Children , Pediatric Endocrinology , Minnesota Medical School , Medscape Medical ,

Insurance often denies GLP-1 medications for teens

Health insurance companies often deny coverage for new medications that treat children and teens with obesity and type 2 diabetes, meaning many patients wh ....

United States , Gabriel Castano , Texas Children Hospital Baylor College Of Medicine , Drug Administration , Endocrine Society , Texas Children , Hospital Baylor College ,

Insurance often denies GLP-1 medications for teens with type 2 diabetes, obesity

Health insurance companies often deny coverage for new medications that treat children and teens with obesity and type 2 diabetes, meaning many patients who need treatment are unable to afford it, according to a study presented at ENDO 2024, the Endocrine Society s annual meeting in Boston, Mass. ....

United States , Gabriel Castano , Drug Administration , Endocrine Society , Texas Children Hospital Baylor College Of Medicine , Texas Children , Hospital Baylor College ,

Insurance denials may pose substantial barrier to GLP-1 drugs for teens

BOSTON — From 2019 to 2023, insurance covered GLP-1 receptor agonist prescriptions at a Texas hospital for less than 70% of young people with type 2 diabetes and less than 40% of those with obesity.In addition, 44% of pediatric patients with obesity and 17% with type 2 diabetes prescribed liraglutide (Saxenda, Victoza; Novo Nordisk) discontinued the medication before reaching the approved ....

Baylor College Of Medicine , United States , Byjill Rollet , Richard Smith , Stephanie Sisley , Bydureon Bcise , Eli Lilly , Gabriel Castano , Novo Nordisk , Texas Children , Baylor College ,